Published in:

01-11-2004

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002

Authors: Tomohiro Kinoshita, Tomomitsu Hotta, Kensei Tobinai, Tohru Kobayashi, Naoki Ishizuka, Masao Tomonaga, Toshiaki Sai, Youichiro Ohno, Masaharu Kasai, Michinori Ogura, Chikara Mikuni, Hironobu Toki, Masayuki Sano, Yasufumi Masaki, Tomoko Ohtsu, Yoshihiro Matsuno, Takeaki Takenaka, Shigeru Shirakawa, Masanori Shimoyama, Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG-LSG)

Published in: International Journal of Hematology | Issue 4/2004